On Tuesday, Plandai Biotechnology Inc (OTCMKTS:PLPL) attempted an up move on the chart and closed with gains of over 3% at $1.97. Unlike its decline on Monday, it sustained the intraday gains and closed in green. However, still there is no clear direction as to where the stock will move from here.
The company recently reported that USN will launch new products that will contain Phytofare® catechin complex. A couple of months ago, Plandai released an update on its Senteeko Tea Estate located in South Africa. The company owns numerous tea fields that cultivate the raw components that it uses to develop bio-available green tea extract, ‘Phytofare®.’
This respective tea estate was a matter of attraction for Stock Market Media Group in April. The group had spent a week for documenting Plandai’s story. Its team visited the Senteeko tea estate and cherished the beauty of property. The visit was a learning experience as the team got the information related to the significance of bioavailability and the role Phytofare plays in body.
Metabolix, Inc. (NASDAQ:MBLX) Moves North On The Chart
Metabolix, Inc. (NASDAQ:MBLX) reported the launch of ‘Yield10 Bioscience’ team that will support the development and commercialization measures of company in field of crop science. Yield10 is working on proprietary, breakthrough know-how to enhance major crops yield based on company’s metabolic engineering platform.
As per a report, the global population is estimated to grow to 9 billion from 7 billion by year 2050 resulting in an increase of 70% demand in food production. This expected increase in population and mounting pressure on land and water resources demands new agricultural solutions to enhance yield in energy, food and feed crops worldwide.
One of the company in same sector, Entia Biosciences Inc (OTCMKTS:ERGO) jumped more than 27% in yesterday’s trading session to close at $0.115.
